Human Trials: Scientists, Investors, And Patients In The Quest For A Cure

(7)
Human Trials: Scientists, Investors, And Patients In The Quest For A Cure image
ISBN-10:

0738206776

ISBN-13:

9780738206776

Author(s): Quinn, Susan
Released: May 01, 2002
Publisher: Da Capo Press
Format: Paperback, 318 pages
Related ISBN: 9780738201825

Description:

Susan Quinn's extraordinary story takes the reader into the closed world of experimental "human trials" in which new drugs are developed. Both the portrait of a dedicated scientist and the archetypal story of all medical research, Human Trials is the emotion-laden, roller-coaster trip from the lab bench to the medicine cabinet, in which scientists risk their reputations, venture capitalists their millions, and patients their very lives. A Merloyd Lawrence Book

Best prices to buy, sell, or rent ISBN 9780738206776




Frequently Asked Questions about Human Trials: Scientists, Investors, And Patients In The Quest For A Cure

You can buy the Human Trials: Scientists, Investors, And Patients In The Quest For A Cure book at one of 20+ online bookstores with BookScouter, the website that helps find the best deal across the web. Currently, the best offer comes from and is $ for the .

The price for the book starts from $7.07 on Amazon and is available from 15 sellers at the moment.

If you’re interested in selling back the Human Trials: Scientists, Investors, And Patients In The Quest For A Cure book, you can always look up BookScouter for the best deal. BookScouter checks 30+ buyback vendors with a single search and gives you actual information on buyback pricing instantly.

As for the Human Trials: Scientists, Investors, And Patients In The Quest For A Cure book, the best buyback offer comes from and is $ for the book in good condition.

The Human Trials: Scientists, Investors, And Patients In The Quest For A Cure book is in very low demand now as the rank for the book is 6,050,880 at the moment. A rank of 1,000,000 means the last copy sold approximately a month ago.

Not enough insights yet.